Skip to main content
. 2022 Mar 10;25(5):159. doi: 10.3892/mmr.2022.12676

Table II.

Percentage of intensity score of CK-1ε, DEC1, PCNA and CD44 in ASE and CIS.

Intensity CK-1ε (%) DEC1 (%) PCNA (%) CD44 (%)
ASE
1 90 0 25 75
2 10 30 60 15
3 0 70 15 10
CIS
1 0 75 0 16
2 42 8 50 42
3 58 17 50 42

CK-1ε, casein kinase 1ε; DEC1, differentiated embryonic chondrocyte gene 1; PCNA, proliferating cell nuclear antigen; ASE, atypical squamous epithelium; CIS, carcinoma in situ.